A simple, safe treatment may help protect women after menopause, yet most women who could use it never hear about it.

"It's Probably a UTI" Is More Serious Than It Sounds

October 20, 2026•4 min read

I’ve been wanting to write about this for a long time because I’ve heard this story from clients so many times: A parent or other relative was fine one day, and the next they’re suddenly confused, dangerously weak, or acting completely out of character, often even like a sudden onset of dementia, ending up in the ER.

The story typically ends with, “I think it’s probably a UTI…”

This may be an awkward subject to write about but I can’t put it off any longer. It’s critical that people know how dangerous these infections can be and that there’s a way to significantly minimize the risk.

While a urinary tract infection can be serious in younger women, it can become deadly for older women. Over a million American adults aged 25 and older died from UTI-related causes between 1999 and 2023, and women were twice as likely as men to die this way.

Women over 50 who are hospitalized with a UTI are are over three times as likely to die from it, rising to over 8 times as likely for women over 85.

If you're younger and have had more than one UTI, you need to know that it’s the strongest and most consistent risk factor for UTIs in menopause.

Now you know why I think it’s so important to share this information!

Why postmenopausal women are at such great risk

When estrogen drops, the tissues of the urogenital tract become thinner and lose elasticity. As the lining gets thinner, it loses some of its ability to act as a barrier against bacteria.

The vagina also tends to lose the “good” bacteria, called lactobacilli, that keep the environment acidic and unfriendly to E. coli, the most common cause of UTIs. This combination of changes is called the genitourinary syndrome of menopause. Its symptoms include dryness, itching, and painful sex.

Using continuous low-dose antibiotics is and approach that’s often been used to prevent repeat infections. I’ve had numerous clients on that regime. It works, but comes with downsides, including antibiotic resistance and side effects.

Antibiotics treat active infections, they don't prevent the next one from happening. That’s where proactive prevention comes in.

A different approach that’s proven and underused

The other option is to replace estrogen where it’s needed. This isn’t the same as the pills or patches most of us think of when we hear “hormone therapy,” which haven’t proven to be effective in preventing UTIs.

Unlike systemic hormone therapy, local vaginal estrogen stays where it is applied as a cream, a tablet, or a ring, with minimal absorption into the rest of the body. It restores the natural tissue barrier and healthy microbiome, reducing the risk of recurrent UTIs by more than 50% to 60%.

The American Urological Association’s guideline recommends vaginal estrogen for postmenopausal women with recurrent UTIs.

The evidence for preventing infections is strong:

  • A 1993 trial found that estriol cream cut recurrent UTIs from about 6 per woman per year to about 0.5. It also restored the protective bacteria in the vagina.

  • In another trial, an estradiol-releasing ring cut new UTIs from 45% to 20% over 36 weeks.

  • A meta-analysis of the trials found a roughly 60% reduction in risk.

Is this a miracle cure?

The trials show fewer infections. The bigger claims, that it prevents hospitalizations, sepsis, and even death, come from an observational study, not a randomized trial.

That study found that women who used vaginal estrogen after recurrent UTIs were about half as likely to be hospitalized and about a quarter as likely to develop sepsis, and women aged 55 to 69 were far less likely to die over eight years.

But women who choose a treatment can differ in many ways from those who don’t, such as being more health-conscious or better at navigating the healthcare system. The study authors note that the true benefit is probably smaller than those numbers suggest.

Still, the trials indicate that fewer infections should mean fewer chances for one to turn serious.

Why aren’t more women using it?

In that same study, only about 21% of women aged 55 to 69 with recurrent UTIs had received vaginal estrogen. One of my clients has had multiple recurrent UTIs and only recently had vaginal estrogen recommended to her. The authors point to a lack of awareness among both doctors and women.

And then there’s the lingering fear left over from the 2002 Women’s Health Initiative whose scary headlines about oral hormone therapy have since have since been walked back. That study used an oral combination of Premarin and a synthetic progestin in women who were, on average, already in their 60s. It never tested vaginal estrogen, which stays where it's applied.

Women with a history of breast cancer should certainly have a conversation with their oncologist about any sort of hormonal approach.

If you or someone you love has had repeated UTIs, or has symptoms like dryness, itching, or pain after menopause, ask your doctor about vaginal estrogen. It’s available by prescription and inexpensive.

I hope this information will help keep even just one person out of the hospital!

This post is for information only, not medical advice. Here’s the original article.

Back to Blog